Upside Biotechnologies pulls in Series A funding
New Zealand-based Upside Biotechnologies, a regenerative medicine startup, has raised NZ$2.3 million in Series A funding. ICE Angels Nominees led the round with participation from The University of Auckland Inventors Fund managed by Auckland UniServices, Cure Kids Ventures and New Zealand Venture Investment Fund.
22 March 2017•1 min read
